Home・Elenco Azioni・InflaRx NV

InflaRx NV

Chiusa

2.05 4.59

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.9300000000000002

Massimo

2.07

Metriche Chiave
By Trading Economics
Entrata	3.2M -5.7M
EPS	-0.08
Margine di Profitto	16,200.567
Dipendenti	65
EBITDA	8.5M -5.5M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+337.81% upside

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	148M 302M
Apertura precedente	-2.54
Chiusura precedente	2.05

InflaRx NV Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 lug 2026, 23:56 UTC

Correlated Moves

Skyworks Solutions Inc shares are higher in after-market trading, supported by positive sentiment in the semiconductor sector and strong earnings from major banks.

14 lug 2026, 23:56 UTC

JD.Com Inc. shares advanced in after-market trading, supported by strong earnings from major banks and a positive market backdrop. The stock remains above its 20-day moving average.

14 lug 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is higher in after-market trading, supported by favorable USD/CNH exchange rate movements and contributions from JD.

14 lug 2026, 23:56 UTC

Vanguard Total International Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 lug 2026, 23:56 UTC

iShares National Muni Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 lug 2026, 23:52 UTC

Verisk Analytics Inc shares are lower in after-market hours, with no specific news identified. The decline contrasts with positive sentiment from strong bank earnings.

14 lug 2026, 23:52 UTC

South Korea's June unemployment rate improves to 2.7%, boosting market confidence amid global economic recovery.

14 lug 2026, 23:52 UTC

Brazil's Central Bank to Release Key SELIC Rate Insights Amid Global Inflation Concerns on July 20, 2026.

14 lug 2026, 23:52 UTC

U.S. Industrial Production Data Release on July 17, 2026, Expected to Show Modest Growth Amid Cautious Economic Sentiment and Global Market Volatility.

14 lug 2026, 23:52 UTC

China's Q2 GDP Growth Rate Expected to Slow to 0.9% Amid Strong Export Surge and Cautious Consumer Sentiment

14 lug 2026, 23:52 UTC

Japan's upcoming Exports YoY report on July 21, 2026, is generating cautious optimism among investors amid positive regional trends and strong Chinese export data.

14 lug 2026, 23:52 UTC

Japan's Upcoming Balance of Trade Data on July 21, 2026, Sparks Cautious Investor Sentiment Amidst Persistent Trade Deficits and Global Commodity Price Fluctuations.

14 lug 2026, 23:51 UTC

U.S. Inflation Drops More Than Expected, Boosting European Equity Futures Amid Geopolitical Tensions

14 lug 2026, 23:51 UTC

U.S. inflation drops unexpectedly, boosting global equity markets despite mixed results in the U.S. and ongoing geopolitical tensions affecting oil prices.

14 lug 2026, 23:51 UTC

Asian equity markets rise on strong Chinese trade data, while U.S. stock futures react to softer inflation and mixed earnings amid geopolitical tensions.

14 lug 2026, 23:51 UTC

U.S. equity markets show mixed results as weaker-than-expected inflation data eases rate hike fears, while geopolitical tensions and strong bank earnings drive volatility.

14 lug 2026, 23:46 UTC

ETF Constituents

iShares Core MSCI EAFE ETF declines in after-market hours, influenced by top holdings BHP and TM. Performance remains flat since Tuesday's close.

14 lug 2026, 23:46 UTC

ETF Constituents

iShares Biotechnology ETF declines in after-hours trading, continuing a trend of lower daily closes amid declines from key holdings like EDIT and ADPT.

14 lug 2026, 23:46 UTC

MercadoLibre Inc shares are higher in after-market hours, supported by strong bank earnings that eased interest rate concerns. No specific news was identified for the stock.

14 lug 2026, 23:46 UTC

News

PayPal Holdings Inc. shares are lower in after-market trading despite expanding buy now, pay later options in the UK with a new Pay in 30 Days feature.

14 lug 2026, 23:42 UTC

Japan's Machinery Orders Expected to Decline by -4.2% MoM Amid Geopolitical Tensions and Market Caution

14 lug 2026, 23:42 UTC

China's Fixed Asset Investment Expected to Contract Further Amid Weak Economic Indicators and Cautious Market Sentiment

14 lug 2026, 23:42 UTC

China's Industrial Production YoY data for June 2026, expected to rise to 4.6%, set for release on July 15 amid cautious optimism influenced by strong trade figures and geopolitical tensions.

14 lug 2026, 23:42 UTC

China's Retail Sales Expected to Decline by 0.1% YoY Amid Mixed Economic Signals Ahead of July Release

14 lug 2026, 23:42 UTC

China's Q2 2026 GDP Growth Rate Expected at 4.5%, Amid Mixed Economic Signals and Global Uncertainties

14 lug 2026, 23:42 UTC

Bank of Canada's Monetary Policy Report on July 15, 2026, expected to maintain interest rates amid stable inflation and geopolitical tensions.

14 lug 2026, 23:41 UTC

Event

News

Biogen Inc shares are higher in after-market trading following positive Phase 2 CELIA study results for diranersen, which targets tau in early Alzheimer's disease.

14 lug 2026, 23:41 UTC

Macro Event

Correlated Moves

Macro News

Crude oil prices have risen, reaching $79 per barrel amid U.S.-Iran tensions. The EUR/USD exchange rate is modestly higher since Monday's close.

14 lug 2026, 23:41 UTC

Macro News

Macro Event

Correlated Moves

Bitcoin is rising as geopolitical tensions boost oil prices and soft U.S. inflation data eases rate hike fears. Ethereum's gains may further support Bitcoin's momentum.

14 lug 2026, 23:36 UTC

Autodesk Inc shares advanced after-market, reaching a high of 0.78% since Tuesday's close, despite no specific news driving the movement.

Confronto tra pari

Modifica del prezzo

InflaRx NV Previsione

Obiettivo di Prezzo

By TipRanks

337.81% in crescita

Previsioni per 12 mesi

Media 8.8 USD 337.81%

Alto 14 USD

Basso 4 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per InflaRx NV - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

6 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 6 che hanno fornito valutazioni azionarie a InflaRx NV - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo InflaRx NV

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.